---
name: Tigermed
slug: tigermedgrp
site: cro
website_domain: tigermedgrp.com
summary: Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers. Headquartered in Hangzhou, China.
tagline: Integrated CRO platform enabling life-changing therapies with end-to-end clinical and preclinical services globally.
founded_year: 2004
employee_count_band: 5001+
employee_count_label: 5,001+
parent_name: 
parent_slug: 
hq_country: CN
tier2_domain_verified: false
updated_at: 2026-07-30T03:52:55.432Z
services_count: 37
modalities_count: 9
indications_count: 10
locations_count: 2
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Tigermed

Integrated CRO platform enabling life-changing therapies with end-to-end clinical and preclinical services globally.

Listed on cro.directory.

## Summary

Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers. Headquartered in Hangzhou, China.

## At a glance

- Founded: 2004
- Employees (est.): 5,001+
- HQ country: CN

## Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Clinical Trial Services
- Clinical Imaging Core Lab
- Central Laboratory Services
- Medical Writing
- Pharmacovigilance & Drug Safety
- Biostatistics & Statistical Programming
- Data Management & eClinical
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- China NMPA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- Device & Combination Product Services
- Translational Research
- GLP Toxicology
- In Vitro ADME / DMPK
- In Vitro Pharmacology
- Preclinical In Vitro Studies
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Medicinal Chemistry
- High-Throughput Screening
- Oncology Specialty Services
- Cardiovascular & Metabolic Specialty Services
- CNS Specialty Services
- Immunology & Inflammation Services
- Virology Services
- Microbiology Services

## Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Vaccine
- Cell Therapy
- Gene Therapy
- Radiopharmaceutical
- Oligonucleotide
- Peptide

## Indications

- Oncology
- Cardiovascular
- Neurology
- Immunology
- Infectious Disease
- Rare Disease
- Metabolic
- Ophthalmology
- Gastroenterology
- Respiratory

## Locations

- Headquarters, Hangzhou, Zhejiang, China
- Global Offices, Multiple, Global, Multiple (180+ locations across 5 continents)

## Long description

Tigermed is an integrated biopharmaceutical research and development services platform offering comprehensive CRO capabilities across the full drug development lifecycle.

**Service Areas:**
- **Preclinical Development:** Medicinal chemistry, compound screening, DMPK, safety & toxicology, bioanalytical services
- **Clinical Development:** Medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, clinical development strategy, decentralized clinical trials (DCTs), site management (SMO)
- **Medical Device & IVD:** Dedicated medical device and in vitro diagnostic CRO services
- **Integrated Capabilities:** Medical imaging, pharmacovigilance, medical translation, quality assurance, GMP consulting, central laboratories, EDC systems, remote follow-up centers
- **Real World Study:** Real-world data and evidence generation for post-marketing studies
- **Therapeutic Expertise:** Cell and gene therapy, GLP-1 RA, radiopharmaceutical, infectious diseases, oncology, hematology, cardiovascular, endocrinology, rheumatology, CNS, gastroenterology, ophthalmology

**Global Reach:** 11,000+ employees across 180+ offices and locations spanning five continents, supporting 4,000+ global customers and 170+ innovative drugs.

## Related companies

- [Medpace](/companies/medpace) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/medpace/tigermedgrp)
- [Premier Research](/companies/premier-research) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/premier-research/tigermedgrp)
- [Labcorp](/companies/labcorp) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/labcorp/tigermedgrp)
- [Certara](/companies/certara) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/certara/tigermedgrp)
- [ICON plc](/companies/iconplc) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/iconplc/tigermedgrp)
- [ICON](/companies/kcrcro) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/kcrcro/tigermedgrp)
- [IQVIA](/companies/iqvia) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/iqvia/tigermedgrp)
- [Syneos Health](/companies/syneoshealth) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/syneoshealth/tigermedgrp)

_Profile last updated: 2026-07-30T03:52:55.432Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.